Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Guns N' Roses 2026 Tour: How to get tickets, presale times, prices and more - 2The most effective method to Pick the Ideal Lab Precious stone Wedding band
- 3Russian authorities threaten WhatsApp with total ban
- 4FDA official discusses potential link between COVID-19 vaccines and pediatric deaths
- 57 Delightful Ferris Wheels, Do You Like Them?
- Video Conferencing Instruments for Virtual Gatherings
- Los Angeles County sees significant uptick in norovirus cases, officials say
- Farmers call for French blockades over cow disease cull
- 6 Web-based Lawful Administrations: Extensive Surveys and Elements
- Vote in favor of the handheld vacuum that you love for its strong attractions!
- Electric discovery on Mars! Scientists find tiny lightning bolts coming from Red Planet dust clouds
- 6 Fun Urban areas For Seniors To Travel
- ONE returns to Red Sea with new service
- The most effective method to Really Adjust Hypothesis and Practice in Your Brain science Studies
